The number of registered users rose from 200,566 in 2021 to 273,664 in 2025. That does not mean the medicine is being used incorrectly. It makes another question important: are benefits, side effects, wearing off and the number of dosing moments evaluated together?
According to the Dutch Zorgcijfersdatabank, an estimated 273,664 people used methylphenidate within reimbursed care in 2025, compared with 200,566 in 2021. That is an increase of 36.4 per cent in four years.
In 2024, GIP recorded an average of 6.01 pharmacy dispensings per methylphenidate user. One dispensing may contain a supply for several weeks and different quantities or strengths. This figure therefore cannot be converted into an average number of tablets per day and does not distinguish immediate-release from prolonged-release products.
The figures do not show whether a prescription was appropriate or unnecessary. They mainly show how many people depend on clear information, monitoring and accessible professional support.
Methylphenidate affects the availability of dopamine and noradrenaline. In ADHD, it may help with attention, impulse control and inner restlessness. How it is experienced throughout the day differs between people and products.
Apotheek.nl states that ordinary tablets often work for three to six hours. A 2016 Dutch adult guideline describes a shorter practical duration of two to three hours and three to eight dosing moments for coverage from morning to evening. This difference shows why a person's experienced duration matters more than one general figure.
Prolonged-release products release the medicine gradually. Depending on the product, a duration of about eight or twelve hours is described. They are not automatically interchangeable because release and absorption may differ. The Dutch Pharmacotherapeutic Compass prefers a prolonged-release product for adults.
Not everyone notices the same changes. A meaningful review considers not only whether you feel something, but whether an ordinary day at home, in education or at work goes better.
Methylphenidate does not remove ADHD and does not automatically solve problems involving sleep, planning, stress, the environment or other symptoms. It can nevertheless be an important and appropriate part of treatment. The continuing question is whether the benefits outweigh the side effects and practical burden.
Eight 10 mg tablets add up to 80 mg a day. That figure cannot be assessed separately from the specific product, release form, person, benefits and side effects.
The 2016 Dutch adult guideline describes three to eight daily dosing moments for immediate-release stimulants when coverage from morning to evening is needed. Current product information lists a maximum of 72 mg for some prolonged-release adult products and a maximum of 80 mg a day for another product. These limits are product-specific and must not be applied to every brand or formulation.
In one anonymously shared experience, 2,910 immediate-release 10 mg tablets were used in one year. That averages almost eight tablets a day; with eight tablets, the daily total was 80 mg. The medicine helped, but the daily pattern also involved several periods of wearing off, rebound symptoms and excessive sweating.
This experience does not show what an appropriate dose is for someone else. It does show why a review should address both the intended benefits and the whole day around them. This is one experience, not a standard or dosing advice.
Not everyone experiences side effects, and a symptom is not automatically caused by methylphenidate. Note when it began, when it occurs during the day and what changed around a medication change.
Increased sweating is listed as a common side effect in the Dutch Pharmacotherapeutic Compass. It can have a substantial practical effect on clothing, work, sleep and social situations. Stimulants may require extra attention during hot weather.
Reduced appetite, weight changes, abdominal symptoms, nausea and dry mouth are described. Discuss persistent symptoms or noticeable weight change, especially when eating becomes a daily struggle.
Difficulty falling asleep, nervousness, headache or irritability may occur. Consider not only the night, but also timing, wearing off and the overall pattern across several days.
Palpitations and changes in heart rate or blood pressure are recognised points for attention. The prescriber determines which checks are needed and when symptoms should be reported sooner.
Physical: heart rate and blood pressure, appetite, weight, sleep, sweating and symptoms such as dizziness, breathlessness or chest pain.
Mental and practical: mood, anxiety, agitation, pronounced emotional blunting, unusual thoughts, daily functioning and a possible urge for more or additional doses.
The treating professional determines which checks are needed and how often. Report new, severe or rapidly worsening symptoms. Do not wait for a routine review when symptoms are acute.
Rebound means a temporary return or intensification of symptoms as the effect wears off. It may be noticed as restlessness, irritability, fatigue, emotional fluctuations or difficulty focusing again.
Not every dip is rebound. Lack of sleep, hunger, stress, the original symptoms or a physical issue may also contribute. Experimenting with additional doses on your own makes the pattern more difficult to assess.
The medication provides noticeably more calm or focus. That can be an important improvement.
Attention focuses mainly on the intended benefit. Sweating, sleep, appetite and wearing off remain separate complaints.
Multiple daily dosing moments become routine, while the practical burden is no longer discussed.
Repeat prescriptions continue, but a review of the entire daily pattern does not happen automatically.
When something changes, it becomes clear how strongly work, sleep and daily planning have been organised around the medicine.
These questions do not point towards a predetermined outcome. They help discuss benefits and burden together.
What change was expected, and how can we tell whether that goal is still being achieved?
Consider not only the best hours, but also the period before the first dose, between doses and while the medicine wears off.
Which symptom has the greatest effect on sleep, eating, work, relationships or daily functioning?
Should the practical burden, timing and differences between products be reviewed again?
Agree which signs are a reason to make contact sooner and when the next review will take place.
Methylphenidate is controlled under the Dutch Opium Act. Do not share it with anyone. A medicine certificate may be needed when travelling abroad. Check this with the CAK well in advance and also review the rules of the destination country.
Check the CAK rules for travelling with medicines →Absorption of medicines may change after bariatric surgery. There is insufficient evidence to give one general answer for methylphenidate. Discuss an unexpectedly weaker or stronger effect with the prescriber and pharmacy, and do not change product or dose on your own.
Read the bariatric surgery dossier →General information does not replace an individual assessment.
Consider not only whether it helps, but how many dosing moments there are, what you notice as it wears off and which side effects have an impact. Share your experience. It may be brief and anonymous.
